This manuscript (permalink) was automatically generated from greenelab/covid19-review@ac89611 on March 23, 2020.
Halie M. Rando
0000-0001-7688-1770
·
rando2
·
tamefoxtime
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
· Funded by the Gordon and Betty Moore Foundation (GBMF 4552)
Casey S. Greene
0000-0001-8713-9213
·
cgreene
·
GreeneScientist
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Childhood Cancer Data Lab, Alex’s Lemonade Stand Foundation, Philadelphia, Pennsylvania, United States of America
· Funded by the Gordon and Betty Moore Foundation (GBMF 4552)
Since late 2019, Coronavirus disease 2019 (COVID-19) has spread around the world, resulting in the declaration of a pandemic by the World Health Organization (WHO). This infectious disease is caused by the newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Research on the virus SARS-CoV-2 and the diease it causes is emerging rapidly through global scientific efforts. The development of diagnostics, treatments, and vaccines will be critical to mitigating the impact of the virus. Here we present a collaborative effort to organize and consolidate the rapidly emerging scientific literature related to SARS-CoV-2. We present information about the virus in the context of what is known about related viruses and synthesize studies emerging about the diagnosis and treatment of COVID-19 alongside literature about related illnesses. A broad scientific effort to understand this pandemic and related viruses and diseases will be foundational to efforts to predict possible interventions. This text is an evolving and collaborative document that seeks to incorporate the ever-expanding body of information related to SARS-CoV-2 and COVID-19.
On January 21, 2020, the World Health Organization (WHO) released its first report concerning what is now known as the Coronavirus disease 2019 (COVID-19) [1]. This infectious disease came to international attention on December 31, 2019 following an announcement by national officials in China about 44 cases of a respiratory infection of unknown cause. The first known cases were located in Wuhan City within the Hubei province of China, but the disease subsequently began to spread rapidly beyond Wuhan within China and around the world. At the time of the first situation report [1], 282 confirmed cases had been identified, primarily in China, but also the first 1 to 2 cases had been found in each of Thailand, Japan, and the Republic of Korea. One week later, 4593 confirmed cases had been identified, spanning not only Asia, but also Australia, North America, and Europe [2]. On March 11, 2020, WHO formally classified the situation as a pandemic [3]. By WHO Situation Report 61, released on March 20, 2020, 266,073 confirmed cases had been reported worldwide, with cases on every continent except Antarctica [4]. At this time, over 11,000 deaths had been reported worldwide.
[Note: Maybe add a graph here, update as new reports come out.]
COVID-19 is caused by the newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a coronavirus, a type of RNA virus known to cause respitatory infections in humans and other species. Other well-known coronaviruses include those associated with previous infectious diseases of global concern, including Severe Accute Repiratory Syndrome (SARS) and Middle East respiratory syndrome (MERS); however, some coronaviruses are associated with less virulent illnesses including the common cold. The SARS-CoV-2 virus was unknown until approximately January 12, 2020, when Chinese officials released its genetic sequence to aid in worldwide efforts to diagnose the disease [1]. As researchers worldwide work to characterize SARS-CoV-2 and COVID-19, information about the transmission and life cycle of the virus as well as the diagnosis and treatment of the disease is emerging rapidly. In this review, we seek to consolidate information about the virus in the context of related viruses and to synthesize what is known about the diagnosis and treatment of COVID-19 and related diseases. This is a real-time, collaborative effort that welcomes submissions from scientists worldwide.
Coronaviruses are RNA viruses that… [Summarize relevant mechanisms for cell entry & address evidence for/against ACE2 being important]
Coronaviruses are known to cause respiratory illnesses in humans through the following possible mechanisms…
Information is rapidly becoming available about the wide range of symptoms that can be associated with COVID-19 as well as the range of symptom severity, onset from exposure, and possible risk or protective factors…
What information is needed to develop a vaccine? How have vaccines for other viruses such as H1N1 been developed?
Two major concerns within diagnosis include the detection of current infections in individuals with and without symptoms, and the detection of past exposure without a live infection. In the latter category, identifying whether individuals can develop or have developed sustained immunity is also a major consideration.
Within therapeutics, some possible efforts include efforts to identify strategies for the management of symptoms as well as the development of antivirals…
In this review, we seek to consolidate information about efforts to develop strategies for diagnosis and therapeutics as new information is released by the scientific community.
This section will include a review of the available information about diagnostics.
This section will include a review of information available about therapeutics.
Author | Competing Interests | Last Reviewed |
---|---|---|
Halie M. Rando | None | 2020-03-22 |
Casey S. Greene | None | 2020-03-22 |
Author | Contributions |
---|---|
Halie M. Rando | Project Administration, Writing - Original Draft, Methodology |
Casey S. Greene | Conceptualization |
This manuscript is a template (aka “rootstock”) for Manubot, a tool for writing scholarly manuscripts. Use this template as a starting point for your manuscript.
The rest of this document is a full list of formatting elements/features supported by Manubot.
Compare the input (.md
files in the /content
directory) to the output you see below.
Bold text
Semi-bold text
Centered text
Right-aligned text
Italic text
Combined italics and bold
Strikethrough
subscript: H2O is a liquid
superscript: 210 is 1024.
unicode superscripts⁰¹²³⁴⁵⁶⁷⁸⁹
unicode subscripts₀₁₂₃₄₅₆₇₈₉
A long paragraph of text. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Putting each sentence on its own line has numerous benefits with regard to editing and version control.
Line break without starting a new paragraph by putting
two spaces at end of line.
Document section headings:
Horizontal rule:
Heading 1
’s are recommended to be reserved for the title of the manuscript.
Heading 2
’s are recommended for broad sections such as Abstract, Methods, Conclusion, etc.
Heading 3
’s and Heading 4
’s are recommended for sub-sections.
Bare URL link: https://manubot.org
Citation by DOI [5].
Citation by PubMed Central ID [6].
Citation by PubMed ID [7].
Citation by Wikidata ID [8].
Citation by ISBN [9].
Citation by URL [10].
Citation by tag [11].
Multiple citations can be put inside the same set of brackets [5,9,11]. Manubot plugins provide easier, more convenient visualization of and navigation between citations [6,7,11,12].
Citation tags (i.e. aliases) can be defined in their own paragraphs using Markdown’s reference link syntax:
Figure 1
Figure 2
Figure 3
Figure 4
Table 1
Equation 1
Equation 2
Quoted text
Quoted block of text
Two roads diverged in a wood, and I—
I took the one less traveled by,
And that has made all the difference.
Code in the middle
of normal text, aka inline code
.
Code block with Python syntax highlighting:
from manubot.cite.doi import expand_short_doi
def test_expand_short_doi():
doi = expand_short_doi("10/c3bp")
# a string too long to fit within page:
assert doi == "10.25313/2524-2695-2018-3-vliyanie-enhansera-copia-i-insulyatora-gypsy-na-sintez-ernk-modifikatsii-hromatina-i-svyazyvanie-insulyatornyh-belkov-vtransfetsirovannyh-geneticheskih-konstruktsiyah"
Code block with no syntax highlighting:
Exporting HTML manuscript
Exporting DOCX manuscript
Exporting PDF manuscript
Bowling Scores | Jane | John | Alice | Bob |
---|---|---|---|---|
Game 1 | 150 | 187 | 210 | 105 |
Game 2 | 98 | 202 | 197 | 102 |
Game 3 | 123 | 180 | 238 | 134 |
Digits 1-33 | Digits 34-66 | Digits 67-99 | Ref. | |
---|---|---|---|---|
pi | 3.14159265358979323846264338327950 | 288419716939937510582097494459230 | 781640628620899862803482534211706 | piday.org |
e | 2.71828182845904523536028747135266 | 249775724709369995957496696762772 | 407663035354759457138217852516642 | nasa.gov |
Colors | ||
---|---|---|
Size | Text Color | Background Color |
big | blue | orange |
small | black | white |
A LaTeX equation:
\[\int_0^\infty e^{-x^2} dx=\frac{\sqrt{\pi}}{2}\](1)
An equation too long to fit within page:
\[x = a + b + c + d + e + f + g + h + i + j + k + l + m + n + o + p + q + r + s + t + u + v + w + x + y + z + 1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9\](2)
WARNING The following features are only supported and intended for .html
and .pdf
exports.
Journals are not likely to support them, and they may not display correctly when converted to other formats such as .docx
.
Adding arbitrary HTML attributes to an element using Pandoc’s attribute syntax:
Manubot Manubot Manubot Manubot Manubot. Manubot Manubot Manubot Manubot. Manubot Manubot Manubot. Manubot Manubot. Manubot.
Adding arbitrary HTML attributes to an element with the Manubot attributes
plugin (more flexible than Pandoc’s method in terms of which elements you can add attributes to):
Manubot Manubot Manubot Manubot Manubot. Manubot Manubot Manubot Manubot. Manubot Manubot Manubot. Manubot Manubot. Manubot.
Available background colors for text, images, code, banners, etc:
white
lightgrey
grey
darkgrey
black
lightred
lightyellow
lightgreen
lightblue
lightpurple
red
orange
yellow
green
blue
purple
Using the Font Awesome icon set:
1.
Cramer
(2020-01-27) https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf
2.
Ikejezie, Mr. Juniorcaius (WDC)
(2020-01-28) https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200128-sitrep-8-ncov-cleared.pdf
3.
Ikejezie, Mr. Juniorcaius (WDC)
(2020-03-11) https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf
4.
Ikejezie, Mr. Juniorcaius (WDC)
(2020-03-21) https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200321-sitrep-61-covid-19.pdf
5. Sci-Hub provides access to nearly all scholarly literature
Daniel S Himmelstein, Ariel Rodriguez Romero, Jacob G Levernier, Thomas Anthony Munro, Stephen Reid McLaughlin, Bastian Greshake Tzovaras, Casey S Greene
eLife (2018-03-01) https://doi.org/ckcj
DOI: 10.7554/elife.32822 · PMID: 29424689 · PMCID: PMC5832410
6. Reproducibility of computational workflows is automated using continuous analysis
Brett K Beaulieu-Jones, Casey S Greene
Nature biotechnology (2017-04) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103790/
DOI: 10.1038/nbt.3780 · PMID: 28288103 · PMCID: PMC6103790
7. Bitcoin for the biological literature.
Douglas Heaven
Nature (2019-02) https://www.ncbi.nlm.nih.gov/pubmed/30718888
DOI: 10.1038/d41586-019-00447-9 · PMID: 30718888
8. Plan S: Accelerating the transition to full and immediate Open Access to scientific publications
cOAlition S
(2018-09-04) https://www.wikidata.org/wiki/Q56458321
9. Open access
Peter Suber
MIT Press (2012)
ISBN: 9780262517638
10. Open collaborative writing with Manubot
Daniel S. Himmelstein, Vincent Rubinetti, David R. Slochower, Dongbo Hu, Venkat S. Malladi, Casey S. Greene, Anthony Gitter
Manubot (2020-01-14) https://greenelab.github.io/meta-review/
11. Opportunities and obstacles for deep learning in biology and medicine
Travers Ching, Daniel S. Himmelstein, Brett K. Beaulieu-Jones, Alexandr A. Kalinin, Brian T. Do, Gregory P. Way, Enrico Ferrero, Paul-Michael Agapow, Michael Zietz, Michael M. Hoffman, … Casey S. Greene
Journal of The Royal Society Interface (2018-04-04) https://doi.org/gddkhn
DOI: 10.1098/rsif.2017.0387 · PMID: 29618526 · PMCID: PMC5938574
12. Open collaborative writing with Manubot
Daniel S. Himmelstein, Vincent Rubinetti, David R. Slochower, Dongbo Hu, Venkat S. Malladi, Casey S. Greene, Anthony Gitter
PLOS Computational Biology (2019-06-24) https://doi.org/c7np
DOI: 10.1371/journal.pcbi.1007128 · PMID: 31233491 · PMCID: PMC6611653